期刊文献+

靶向调节性T细胞治疗的研究进展 被引量:2

下载PDF
导出
摘要 调节性T细胞(Tregs)是一群具有免疫抑制功能的细胞,1995年日本学者Sakaguchi等首次分离出了CD4+CD25+调节性细胞亚群,并证实其具有抑制其他T细胞活化的功能,其主要的特性为免疫无能性及免疫抑制性。Tregs能够显著地抑制宿主的免疫反应和诱导自身免疫耐受。
出处 《临床荟萃》 CAS 2013年第11期1299-1301,共3页 Clinical Focus
  • 相关文献

参考文献16

  • 1Dudley ME, Yang JC, Sherry R, et al. Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens[J]. J Clin Oncol,2008,26(32) :5233-5239.
  • 2Ghiringhelli F, Menard C, Puig PE, et al. Metronomie cyelophosphamide regimen selectively depletes CD4+CD2+ regulatory T cells and restores T and NK effeetor functions in end stage cancer patients [J]. Cancer Immunol Immunother, 2007,56(5):641-648.
  • 3Rech AJ,Vonderheide RH. Clinical use of anti-CD25 antibody daclizumab to enhance immune responses to tumor antigen vaccination by targeting regulatory T cells[J]. Ann N Y Acad Sci,2009,1174 : 99-106.
  • 4Mahnke K, Schonfeld K, Fondel S, et al. Depletion of CD4 + CD25+ human regulatory T cells in vivo: kinetics of Treg depletion and alterations in immune functions in vivo and in vitro[J]. Int J Cancer,2007,120(12) : 2723-2733.
  • 5Peggs KS, Quezada SA, Chambers CA, et al. Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti-CTLA-4 antibodies [J]. J Exp Med,2009,206(8):1717-1725.
  • 6Ansell SM, Hurvitz SA, Koenig PA, et al. Phase I study of ipilimumab, an anti-CTLA-4 monoclonal antibody, in patients with relapsed and refractory B-cell non-Hodgkin lymphoma [J]. Clin Cancer Res, 2009,15 (20): 6446-6453.
  • 7Hodi FS, Butler M, Oble DA, et al. Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte- associated antigen 4 in previously vaccinated cancer patients [J]. Proc Natl Acad Sci USA,2008,105(8) :3005-3010.
  • 8Ko K,Yamazaki S,Nakamura K, et al. Treatment of advanced tumors with agonistic anti-GITRmAb and its effects on tumorin? ltrating Foxp3 + CD25 + CD4 + regulatory T cells [J]. J Exp Med,2005,202(7):885-891.
  • 9Yang Y, Huang CT, Huang X, et al. Persistent Toll-like receptor signals are required for reversal of regulatory T cell- mediated CD8 tolerance [J]. Nat Immunol, 2004, 5 (5) : 508- 515.
  • 10Tan MC, Goedegebuure PS, Belt BA, et al. Disruption of CCRS- dependent homing of regulatory T cells inhibits tumor growth in a rnurine model of pancreatic cancer[J]. J Immunol, 2009, 182(3) : 1746-1755.

同被引文献14

引证文献2

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部